SSG
SRNE

Summit Securities Group’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Summit Securities Group’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,704
Closed -$3K – 1209
2022
Q3 		$3K Buy
+1,704
New +$3K ﹤0.01% 640
2021
Q3 		– Hold
0
– – – 527
2021
Q2 		– Hold
0
– – – 528